当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 现金流量表

万泰生物

(603392)

  

流通市值:889.39亿  总市值:889.39亿
流通股本:12.68亿   总股本:12.68亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金6,674,960,061.815,060,016,993.653,467,546,650.911,641,398,364.94
收到的税费返还144,594,898.873,162,698.25--
收到其他与经营活动有关的现金268,741,865.52219,280,357.1187,104,955.4263,756,008.98
经营活动现金流入的平衡项目0000
经营活动现金流入小计7,088,296,826.25,282,460,0493,654,651,606.331,705,154,373.92
购买商品、接受劳务支付的现金744,666,540.07634,623,399.52461,266,490.44249,776,764.04
支付给职工以及为职工支付的现金1,077,903,323.07840,394,291.54603,670,326.39375,333,354.73
支付的各项税费681,893,952.77509,766,986.6529,011,207.87246,391,910.43
支付其他与经营活动有关的现金3,046,010,083.12,406,600,289.781,894,581,890.421,147,335,700.89
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,550,473,899.014,391,384,967.443,488,529,915.122,018,837,730.09
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,537,822,927.19891,075,081.56166,121,691.21-313,683,356.17
二、投资活动产生的现金流量:
收回投资收到的现金2,090,001,137.722,525,000,0001,265,000,0001,130,000,000
取得投资收益收到的现金66,227,073.1169,155,135.4215,732,875.610,918,540.36
处置固定资产、无形资产和其他长期资产收回的现金净额720,832.08123,676.2119,223.8551,680.27
收到的其他与投资活动有关的现金20,000,0001,125,420.41,125,420.41,125,420.4
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,176,949,042.912,595,404,232.021,281,977,519.851,142,095,641.03
购建固定资产、无形资产和其他长期资产支付的现金1,159,671,679.46867,164,728.09607,984,899.97393,326,983.99
投资支付的现金2,130,300,000714,180--
取得子公司及其他营业单位支付的现金714,180---
支付其他与投资活动有关的现金940,000,0003,235,000,0001,445,000,0001,230,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计4,230,685,859.464,102,878,908.092,052,984,899.971,623,326,983.99
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-2,053,736,816.55-1,507,474,676.07-771,007,380.12-481,231,342.96
三、筹资活动产生的现金流量:
取得借款收到的现金186,439,895.16127,902,101.0155,400,00025,400,000
收到其他与筹资活动有关的现金53,998,245.557,032,332.3756,804,307.2119,500
筹资活动现金流入平衡项目0000
筹资活动现金流入小计240,438,140.66184,934,433.38112,204,307.225,519,500
偿还债务支付的现金148,409,800126,147,40051,749,900497,500
分配股利、利润或偿付利息支付的现金947,474,456.69948,989,012.84930,420,651.541,043,379.35
其中:子公司支付给少数股东的股利、利润40,000,00040,000,00040,000,00040,000,000
支付其他与筹资活动有关的现金37,813,539.3535,567,672.8921,039,750.417,876,830.23
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,133,697,796.041,110,704,085.731,003,210,301.9149,417,709.58
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-893,259,655.38-925,769,652.35-891,005,994.71-23,898,209.58
四、汇率变动对现金及现金等价物的影响7,619,144.029,648,521.6911,207,591.04-3,086,943.45
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,401,554,400.72-1,532,520,725.17-1,484,684,092.58-821,899,852.16
加:期初现金及现金等价物余额5,185,196,205.795,185,196,205.795,185,196,205.795,185,196,205.79
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,783,641,805.073,652,675,480.623,700,512,113.214,363,296,353.63
补充资料:
净利润1,246,504,389.95-1,709,329,395.58-
资产减值准备459,732,643.89-33,035,244.5-
固定资产和投资性房地产折旧187,166,613.96-87,889,242.77-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧187,166,613.96-87,889,242.77-
无形资产摊销28,120,375.92-9,724,993.79-
长期待摊费用摊销24,099,528.66-124,087,264.66-
处置固定资产、无形资产和其他长期资产的损失-221,616.08-304,506.23-
固定资产报废损失1,304,950.43-708,335.12-
公允价值变动损失-24,657,151.78--12,302,538.45-
财务费用-758,773.68--47,442,514.48-
投资损失-98,897,934.56--33,656,260.46-
递延所得税-109,100,693.41--27,727,574.11-
其中:递延所得税资产减少-91,949,921.37--28,447,836.94-
递延所得税负债增加-17,150,772.04-720,262.83-
存货的减少-218,344,025.5--231,051,614.28-
经营性应收项目的减少984,811,064.17--760,596,577.74-
经营性应付项目的增加-935,616,463.37--741,950,268.8-
现金的期末余额3,783,641,805.07-3,700,512,113.21-
减:现金的期初余额5,185,196,205.79-5,185,196,205.79-
公告日期2024-03-292023-10-282023-08-252023-04-21
审计意见(境内)标准无保留意见
TOP↑